It's possible that some stocks could fly higher with the policy change being considered by the Biden administration.
News & Analysis: Abbott Laboratories
Want to play it safe in a volatile market? Go for these three top-notch healthcare picks.
Buy-and-hold investors will want to consider this medical-devices company instead.
This well-established company offers revenue growth many newer players would envy.
Coronavirus testing won't last forever, but the future still looks bright for Abbott Labs.
Luckily, coronavirus tests aren't this company's only rising source of revenue.
Its dividend track record, reputation, and unshakeable growth prospects set it apart from the rest.
These stocks were successful last year -- and the future looks even brighter.
And their payout ratios are still well below 50%
A top Wall Street analyst increased the price target for the healthcare giant.